NRx Pharmaceuticals (NRXPW) Competitors $0.07 -0.02 (-21.35%) As of 08:37 AM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsFinancialsSEC FilingsShort InterestTrends NRXPW vs. ATNFW, LBPSW, AARD, AEHAW, AIMDW, ALVOW, ACABW, BFRIW, BTMDW, and BCTXWShould you be buying NRx Pharmaceuticals stock or one of its competitors? The main competitors of NRx Pharmaceuticals include 180 Life Sciences (ATNFW), 4D pharma (LBPSW), Aardvark Therapeutics (AARD), Aesther Healthcare Acquisition (AEHAW), Ainos (AIMDW), Alvotech (ALVOW), Atlantic Coastal Acquisition Corp. II (ACABW), Biofrontera (BFRIW), biote (BTMDW), and BriaCell Therapeutics (BCTXW). These companies are all part of the "pharmaceutical products" industry. NRx Pharmaceuticals vs. 180 Life Sciences 4D pharma Aardvark Therapeutics Aesther Healthcare Acquisition Ainos Alvotech Atlantic Coastal Acquisition Corp. II Biofrontera biote BriaCell Therapeutics NRx Pharmaceuticals (NASDAQ:NRXPW) and 180 Life Sciences (NASDAQ:ATNFW) are both medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their earnings, profitability, dividends, valuation, community ranking, media sentiment, analyst recommendations, institutional ownership and risk. Does the MarketBeat Community believe in NRXPW or ATNFW? NRx Pharmaceuticals and 180 Life Sciences both received 0 outperform votes by MarketBeat users. CompanyUnderperformOutperformNRx PharmaceuticalsN/AN/A180 Life SciencesN/AN/A Does the media favor NRXPW or ATNFW? In the previous week, NRx Pharmaceuticals had 1 more articles in the media than 180 Life Sciences. MarketBeat recorded 2 mentions for NRx Pharmaceuticals and 1 mentions for 180 Life Sciences. 180 Life Sciences' average media sentiment score of 1.87 beat NRx Pharmaceuticals' score of 0.43 indicating that 180 Life Sciences is being referred to more favorably in the news media. Company Overall Sentiment NRx Pharmaceuticals Neutral 180 Life Sciences Very Positive Is NRXPW or ATNFW more profitable? Company Net Margins Return on Equity Return on Assets NRx PharmaceuticalsN/A N/A N/A 180 Life Sciences N/A N/A N/A Which has stronger earnings and valuation, NRXPW or ATNFW? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioNRx PharmaceuticalsN/AN/AN/AN/AN/A180 Life SciencesN/AN/AN/AN/AN/A SummaryNRx Pharmaceuticals and 180 Life Sciences tied by winning 1 of the 2 factors compared between the two stocks. Remove Ads Get NRx Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for NRXPW and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart NRXPW vs. The Competition Export to ExcelMetricNRx PharmaceuticalsBiotechnology IndustryMedical SectorNASDAQ ExchangeMarket CapN/A$115.14M$5.62B$7.92BDividend YieldN/A3.69%4.89%4.05%P/E RatioN/A3.1923.6218.71Price / SalesN/A4,048.97370.79118.20Price / CashN/A13.0138.0534.64Price / BookN/A35.556.844.17Net IncomeN/A-$87.82M$3.19B$247.07M7 Day PerformanceN/A62.33%5.23%-2.96%1 Month PerformanceN/A59.49%-1.16%-10.88%1 Year PerformanceN/A93.98%12.28%0.34% NRx Pharmaceuticals Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)NRXPWNRx PharmaceuticalsN/A$0.07-21.3%N/A-36.2%$0.00N/A0.00N/AShort Interest ↑Gap DownATNFW180 Life SciencesN/A$0.01+3.0%N/A+34.9%$0.00N/A0.007Positive NewsGap DownLBPSW4D pharmaN/AN/AN/AN/A$0.00$522,000.000.00N/AAARDAardvark TherapeuticsN/A$12.00-5.7%N/AN/A$0.00N/A0.0018Analyst ForecastAnalyst RevisionNews CoveragePositive NewsAEHAWAesther Healthcare AcquisitionN/A$0.03+17.0%N/A-93.3%$0.00N/A0.002Gap UpAIMDWAinosN/A$0.08-12.0%N/A+79.7%$0.00$40,633.000.0040Positive NewsGap UpALVOWAlvotechN/A$2.05-6.8%N/A-58.0%$0.00$391.87M0.004Short Interest ↑News CoverageGap DownACABWAtlantic Coastal Acquisition Corp. IIN/A$0.03-2.9%N/AN/A$0.00N/A0.004Gap DownBFRIWBiofronteraN/A$0.08+36.4%N/A-6.0%$0.00$35.36M0.0070Positive NewsGap UpBTMDWbioteN/A$0.08-22.7%N/A-89.4%$0.00$193.06M0.00N/AGap DownBCTXWBriaCell TherapeuticsN/A$0.10-5.0%N/A-92.7%$0.00N/A0.008Short Interest ↑News CoveragePositive NewsGap Down Remove Ads Related Companies and Tools Related Companies 180 Life Sciences Competitors 4D pharma Competitors Aardvark Therapeutics Competitors Aesther Healthcare Acquisition Competitors Ainos Competitors Alvotech Competitors Atlantic Coastal Acquisition Corp. II Competitors Biofrontera Competitors biote Competitors BriaCell Therapeutics Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:NRXPW) was last updated on 3/13/2025 by MarketBeat.com Staff From Our PartnersElon Musk Wants to Audit Fort Knox—What It Means for Your RetirementYou can take advantage of the coming tariff-fueled gold melt-up right inside your IRA or 401(k) – 100% TAX-FRE...Colonial Metals | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | SponsoredYour Wealth is Under AttackHave you looked at the stock market recently? Millions of investors are scrambling trying to figure out what's...American Alternative | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredAlert: DOGE goes liveElon will most likely be at the helm of it all. And just days from now, could bring about the biggest econo...Altimetry | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredTrump doesn’t give a damnPorter Stansberry: “I met with Trump’s biggest backers… they’re scooping up these 10 stocks” I recently met...Porter & Company | SponsoredA brutally honest economic warning for 2025 (see proof)New York Times best-selling financial author and world-renowned economist Addison Wiggin (a man who’s worked s...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NRx Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share NRx Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
